Brief: Abivax Announces Presentation of Seven Abstracts for Obefazimod in Ulcerative Colitis at 2025 European Crohn’s and Colitis Organization 20th Annual Congress
23/01/2025 22:58
Jan 23 (Reuters) - Abivax SA ABVX.PA :
* EQS-NEWS: ABIVAX ANNOUNCES PRESENTATION OF SEVEN ABSTRACTS
FOR
OBEFAZIMOD IN ULCERATIVE COLITIS AT 2025 EUROPEAN CROHN’S AND
COLITIS ORGANIZATION 20TH ANNUAL CONGRESS
Source text: ID:nEQ9vhNz8a
Further company coverage: ABVX.PA
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Abivax SA
See all newsAbivax shares fall after rival drug data, trader says
France's Abivax H1 net loss widens on higher expenses driven by clinical programs
U.S. RESEARCH ROUNDUP-Caseys General Stores, Targa Resources, United Rentals
GS starts Abivax at 'buy,' sees multibillion sales potential for lead drug candidate
Europe's STOXX 600 ends week at all-time high on earnings support, soft US jobs data